英文别名:
7,11-Diethyl-10-hydroxycamptothecin;(4S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione (ACI);(S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;XIS57GM9TN;7,11-Diethyl-10-hydroxy camptothecin [USP];7,11-diethyl-10-hydroxy camptothecin;1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,8,11-triethyl-4,9-dihydroxy-, (4S)-;(S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione;947687-01-6;(4S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Irinotecan USP Impurity G;SCHEMBL5649602;CS-0164094;(S)-4,8,11-TRIETHYL-4,9-DIHYDROXY-1H-PYRANO[3?,4?:6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14-(4H,12H)-DIONE;(19S)-6,10,19-triethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;AC8365;(S)-4,8,11-triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione? (Irinotecan Impurity pound(c);(S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione;XMB68701;(4S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione;UNII-XIS57GM9TN;(S)-4,8,11-Triethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;7,11-DIETHYL-10-HYDROXY CAMPTOTHECIN [USP IMPURITY];